97 related articles for article (PubMed ID: 2311061)
21. Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II study.
Barone C; Cassano A; Astone A; Ricevuto E; Fontana T; Noviello MR; Garufi C; Pacelli F; Grieco A
Oncology; 1991; 48(5):353-5. PubMed ID: 1745479
[TBL] [Abstract][Full Text] [Related]
22. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
[TBL] [Abstract][Full Text] [Related]
23. FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
Bajetta E; Di Bartolomeo M; Carnaghi C; Buzzoni R; Mariani L; Gebbia V; Comella G; Pinotti G; Ianniello G; Schieppati G; Bochicchio AM; Maiorino L
Br J Cancer; 1998 Apr; 77(7):1149-54. PubMed ID: 9569054
[TBL] [Abstract][Full Text] [Related]
24. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
Chung YS; Yamashita Y; Inoue T; Matsuoka T; Nakata B; Onoda N; Maeda K; Sawada T; Kato Y; Shirasaka T; Sowa M
Cancer; 1997 Jul; 80(1):1-7. PubMed ID: 9210702
[TBL] [Abstract][Full Text] [Related]
25. Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer.
Preusser P; Wilke H; Achterrath W; Fink U; Lenaz L; Heinicke A; Meyer J; Meyer HJ; Buente H
J Clin Oncol; 1989 Sep; 7(9):1310-7. PubMed ID: 2671287
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann JT; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C
Br J Cancer; 2000 Aug; 83(4):458-62. PubMed ID: 10945491
[TBL] [Abstract][Full Text] [Related]
27. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
Kim YH; Kim BS; Seo JH; Choi CW; Kim JS; Chun HJ; Hyun JH; Kim JS
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):64-8. PubMed ID: 10442365
[TBL] [Abstract][Full Text] [Related]
28. A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma.
Spiridonidis CH; Laufman LR; Jones JJ; Gray DJ; Cho CC; Young DC
Cancer; 1996 Nov; 78(10):2070-7. PubMed ID: 8918399
[TBL] [Abstract][Full Text] [Related]
29. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM
Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
[TBL] [Abstract][Full Text] [Related]
30. [A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
Ono T; Komatsu M; Hoshino T; Ishii T; Fujii K; Ohshima S; Mikami K; Masamune O; Fukuda T
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1709-12. PubMed ID: 8886050
[TBL] [Abstract][Full Text] [Related]
31. A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.
Park SR; Oh DY; Kim DW; Kim TY; Heo DS; Bang YJ; Kim NK; Kang WK; Kim HT; Im SA; Suh JH; Kim HK; Kim HK
Oncol Rep; 2004 Nov; 12(5):1059-64. PubMed ID: 15492793
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
Asamoto H; Kawahara M; Iwami F; Kuba M; Furuse K; Tamura T; Saijo N; Shimoyama M
Jpn J Clin Oncol; 1998 Dec; 28(12):745-8. PubMed ID: 9879292
[TBL] [Abstract][Full Text] [Related]
33. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
Irino S; Fujita J; Yamaji Y; Futami H; Hashimoto Y; Bungo M; Iuchi Y; Kamei M; Nakamura H; Hata Y
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
[TBL] [Abstract][Full Text] [Related]
34. [Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study].
Hu B; Yu JR; Wen ZZ; Shu YQ; Wang BC; Yin HR; Chen L; Bai YX; Liang J; Chen L; Cheng Y; Shen L; Zhou Y; Zhang HG; Li J; Wan DS; Chen S; Jia TZ; Jin ML
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):940-3. PubMed ID: 19173999
[TBL] [Abstract][Full Text] [Related]
35. Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)".
Räth U; Flechtner H; Selbach J; Harjung H; Manegold C; Kabelitz K; Trux FA; Edler L; Schlag P; Queisser W
Onkologie; 1990 Jun; 13(3):194-7. PubMed ID: 2204005
[TBL] [Abstract][Full Text] [Related]
36. Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ Cooperative Group.
González-Barón M; Feliu J; Espinosa E; García-Girón C; Chacón I; Garrido P; Colmenarejo A; Ordóñez A; Zamora P
Cancer Chemother Pharmacol; 1995; 36(3):255-8. PubMed ID: 7781148
[TBL] [Abstract][Full Text] [Related]
37. A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer.
Fukuoka M; Masuda N; Negoro S; Takada M; Kudoh S; Kusunoki Y; Matsui K; Takifuji N; Tachikawa A; Kawahara M
Cancer; 1991 Jul; 68(2):284-8. PubMed ID: 2070326
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.
Kim YH; Shin SW; Kim BS; Kim JH; Kim JG; Mok YJ; Kim CS; Rhyu HS; Hyun JH; Kim JS
Cancer; 1999 Jan; 85(2):295-301. PubMed ID: 10023695
[TBL] [Abstract][Full Text] [Related]
39. Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
Miller AA; Herndon JE; Hollis DR; Ellerton J; Langleben A; Richards F; Green MR
J Clin Oncol; 1995 Aug; 13(8):1871-9. PubMed ID: 7636529
[TBL] [Abstract][Full Text] [Related]
40. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
